上海中医药大学附属龙华医院脾胃病研究所，研究员，硕士生导师

复旦大学理学博士；巴黎十一大学/国家健康与医学研究院博士后；渥太华大学访问学者。中国中西医结合学会肝病分会委员、中国研究型学会中西医整合脾胃消化病专委会委员、上海市中医药学会肝病专业委员会委员。

从事脂肪肝、肝癌等消化性疾病中西医结合防治研究。主持科研项目12项，包括2项国自然。以第一/通讯作者发表论文50余篇。获发明专利授权4项，上海市/教育部科技奖3项。

主要研究成果：

(1)Huang P #,Yang L#, Liu T, Jiang Y, Chen Z, Song H*, Zheng P*. Scoparone alleviates nonalcoholic fatty liver disease by modulating the PPARα signaling pathway. Eur J Pharmacol. 2024 Oct 4;984:177033. 

(2)Zhang X#, Zhao Y#, Li M#, Wang M, Qian J, Wang Z, Wang Y, Wang F, Guo K, Gao D, Zhao Y, Chen R, Ren Z, Song H*, Cui J*. A synergistic regulation works in matrix stiffness-driven invadopodia formation in HCC. Cancer Lett. 2024 Feb 1;582:216597. 

(3)Li Y#, Liu Y#, Chen Z#, Tang K, Yang L, Jiang Y, Wang J, Huang P, Wang J*, Zheng P*, Song H*. Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK/SIRT1 signaling pathway. Biomed Pharmacother. 2023 Jan 30;160:114319.

(4)Chen Z#, Yang L#, Liu Y, Huang P, Song H* and Zheng P*, The potential function and clinical application of FGF21 in metabolic diseases. Front. Pharmacol. 2022 Dec 21;13:1089214. 

(5)Yang Liu#, Yiping Li#, Jue Wang#, Lili Yang, Xiao Yu, Ping Huang, Haiyan Song*, Peiyong Zheng*. Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway. BMC Complement Med Ther. 2022 Aug 9; 22(1):213.